Ειδήσεις: TERNS PHARMACEUTICALS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

29/03 08:17 defenseworld.net

Investors Purchase High Volume of Put Options on Terns Pharmaceuticals (NASDAQ:TERN)

Terns Pharmaceuticals Merck acquisition put options stock rally oncology leukemia

27/03 07:40 defenseworld.net

Equities Analysts Offer Predictions for TERN FY2030 Earnings

Terns Pharmaceuticals FY2030 earnings HC Wainwright UBS TD Cowen price objective

26/03 11:07 defenseworld.net

E. Ohman J or Asset Management AB Sells 81,208 Shares of Terns Pharmaceuticals, Inc. $TERN

Asset Management AB Terns Pharmaceuticals share sale portfolio adjustment NASDAQ investment

25/03 21:05 bloomberg.com

Merck to Buy Terns for $6.7B to Grow in Blood Cancers

Merck Terns Pharmaceuticals leukemia oncology drug acquisition patent expiration

25/03 16:57 yahoo.com

Merck to acquire Terns Pharmaceuticals for $6.7B

Merck Terns Pharmaceuticals acquisition oncology immunology $6.7B

25/03 13:35 marketwatch.com

Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal

Merck Terns Pharmaceuticals oncology leukemia acquisition $6.7B

25/03 12:51 investing.com

Merck to buy oncology firm Terns Pharmaceuticals in $6.7 billion deal

Merck Terns Pharmaceuticals oncology acquisition $6.7 billion targeted therapies

25/03 03:16 bloomberg.com

Merck Nears Deal to Buy Terns Pharmaceuticals

Merck Terns Pharmaceuticals acquisition biotech U.S. market drug pipeline

25/03 03:16 bloomberg.com

Merck Nears Deal to Buy Terns Pharmaceuticals

Merck Terns Pharmaceuticals acquisition biotech U.S. market drug pipeline

Loading...